Anti-PD-1 therapy with nivolumab after allo-HSCT for Hodgkin lymphoma
Crossref DOI link: https://doi.org/10.1038/nrclinonc.2017.50
Published Online: 2017-03-29
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Killock, David
Text and Data Mining valid from 2017-03-29
Article History
First Online: 29 March 2017